186 related articles for article (PubMed ID: 35744792)
1. Dystrophin Protein Quantification as a Duchenne Muscular Dystrophy Diagnostic Biomarker in Dried Blood Spots Using Multiple Reaction Monitoring Tandem Mass Spectrometry: A Preliminary Study.
Nimer RM; Sumaily KM; Almuslat A; Abdel Jabar M; Sabi EM; Al-Muhaizea MA; Abdel Rahman AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744792
[TBL] [Abstract][Full Text] [Related]
2. CFTR protein quantification as a cystic fibrosis diagnostic biomarker in dried blood spots using multiple reaction monitoring tandem mass spectrometry.
Sumaily KM; Nimer R; Alzahrani M; Abdel Jabar M; Alodib A; Sabi EM; Nizami I; Abdel Rahman AM
J Pharm Biomed Anal; 2022 Jul; 216():114801. PubMed ID: 35504217
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy.
Farrokhi V; Walsh J; Palandra J; Brodfuehrer J; Caiazzo T; Owens J; Binks M; Neelakantan S; Yong F; Dua P; Le Guiner C; Neubert H
Gene Ther; 2022 Nov; 29(10-11):608-615. PubMed ID: 34737451
[TBL] [Abstract][Full Text] [Related]
4. A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring.
Rossi R; Johansson C; Heywood W; Vinette H; Jensen G; Tegel H; Jiménez-Requena A; Torelli S; Al-Khalili Szigyarto C; Ferlini A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982290
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle.
Tominari T; Takatoya M; Matsubara T; Matsunobe M; Arai D; Matsumoto C; Hirata M; Yoshinouchi S; Miyaura C; Itoh Y; Komaki H; Takeda S; Aoki Y; Inada M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203473
[TBL] [Abstract][Full Text] [Related]
6. Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.
Beekman C; Janson AA; Baghat A; van Deutekom JC; Datson NA
PLoS One; 2018; 13(4):e0195850. PubMed ID: 29641567
[TBL] [Abstract][Full Text] [Related]
7. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
Maruyama R; Yokota T
Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
[TBL] [Abstract][Full Text] [Related]
8. The discovery of the DNA methylation episignature for Duchenne muscular dystrophy.
Schreyer L; Reilly J; McConkey H; Kerkhof J; Levy MA; Hu J; Hnaini M; Sadikovic B; Campbell C
Neuromuscul Disord; 2023 Jan; 33(1):5-14. PubMed ID: 36572586
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
10. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
[TBL] [Abstract][Full Text] [Related]
11. Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.
Wilson K; Faelan C; Patterson-Kane JC; Rudmann DG; Moore SA; Frank D; Charleston J; Tinsley J; Young GD; Milici AJ
Toxicol Pathol; 2017 Oct; 45(7):961-976. PubMed ID: 28974147
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
[TBL] [Abstract][Full Text] [Related]
13. Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients.
Hassan MJ; Mahmood S; Ali G; Bibi N; Waheed I; Rafiq MA; Ansar M; Ahmad W
Pediatr Int; 2008 Apr; 50(2):162-6. PubMed ID: 18353051
[TBL] [Abstract][Full Text] [Related]
14. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
15. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
Hoffman EP
Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
[TBL] [Abstract][Full Text] [Related]
16. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
17. [Detection of new mutations in the dystrophin gene by denaturing high-performance liquid chromatography].
Chen YN; Zhou X; Jin CL; Xu Y; Lin CK; Cao LH; Li N; Zhang X; Luo Y
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):413-6. PubMed ID: 17880784
[TBL] [Abstract][Full Text] [Related]
18. CRISPR Therapeutics for Duchenne Muscular Dystrophy.
Erkut E; Yokota T
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163754
[TBL] [Abstract][Full Text] [Related]
19. Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen.
Anthony K; Feng L; Arechavala-Gomeza V; Guglieri M; Straub V; Bushby K; Cirak S; Morgan J; Muntoni F
Hum Gene Ther Methods; 2012 Oct; 23(5):336-45. PubMed ID: 23075107
[TBL] [Abstract][Full Text] [Related]
20. A highly sensitive and quantitative assay for dystrophin protein using Single Molecule Count Technology.
Ishii MN; Quinton M; Kamiguchi H
Neuromuscul Disord; 2023 Oct; 33(10):737-743. PubMed ID: 37666691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
